David Hoang

Stock Analyst at Deutsche Bank

(0)
# 4579
Out of 5,297 analysts
43
Total ratings
40.00%
Success rate
-17.41%
Average return
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
ALKS Alkermes
Maintains: Strong Buy
40 52
32.66 59.22% 2 Mar 27, 2025
SRPT Sarepta Therapeutics
Maintains: Hold
124 99
62.33 58.83% 6 Mar 19, 2025
XENE Xenon Pharmaceutical...
Initiates Coverage On: Buy
67
31.45 113.04% 3 Feb 11, 2025
PRAX Praxis Precision Med...
Initiates Coverage On: Buy
111
37.12 199.03% 1 Feb 11, 2025
HRMY Harmony Biosciences
Initiates Coverage On: Buy
55
32.54 69.02% 2 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
31
13.76 125.29% 3 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
65
23.68 174.49% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
176
109.9 60.15% 4 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
7.46 60.86% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 23
16.63 38.3% 4 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
150 158
108.3 45.89% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
45 50
n/a n/a 3 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
1.07 554.21% 1 Jul 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
8
7.78 2.83% 1 May 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
3.7 332.43% 1 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
3.42 367.84% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
220
267.06 -17.62% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
80
12.72 528.93% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 25
n/a n/a 1 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3
0.99 203.03% 1 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 1, 2022